PRVB News and Press, Provention Bio Inc. From 11/06/21

Image source: The Motley Fool. Provention Bio, inc (NASDAQ: PRVB) Q3 2021 Earnings Call Nov 5, 2021 , 2:00 p.m. ET Operator Continue reading For further details see: Provention Bio, inc (PRVB) Q3 2021 Earnings Call Transcript

Provention Bio Appoints Miguel Sanjuan, Ph.D. as Senior Vice President of Research and Early Development PR Newswire RED BANK, N.J. , Nov. 5, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and ...

Provention Bio, Inc. (PRVB) Q3 2021 Earnings Conference Call November 4, 2021 8:30 a.m. ET Company Participants Ashleigh Palmer - Co-Founder, President, CEO, & Director Andrew Drechsler - CFO Francisco Leon - Co-Founder & Chief Scientific Officer Jason Hoitt - Chief Commercial Officer...

The following slide deck was published by Provention Bio, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Provention Bio, Inc. 2021 Q3 - Results - Earnings Call Presentation

Provention Bio (NASDAQ:PRVB) appointed Thierry Chauche as its CFO, effective Dec.1, 2021 as Andrew Drechsler will be retiring post his ~30 years tenure in the financial and life sciences industry, most notably, the past four years at Provention Bio. Mr. Drechsler will...

Provention Bio (NASDAQ:PRVB): Q3 GAAP EPS of -$0.43 beats by $0.07. Revenue of $0.68M misses by $0.57M. Press Release For further details see: Provention Bio EPS beats by $0.07, misses on revenue

Provention Bio Announces Appointment of Thierry Chauche as Chief Financial Officer Andrew Drechsler to Retire as Chief Financial Officer in December PR Newswire RED BANK, N.J. , Nov. 4, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharm...

Provention Bio Reports Third Quarter 2021 Financial Results and Provides Business Update PR Newswire RED BANK, N.J. , Nov. 4, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immun...

ABC, ABUS, ACIW, ADAP, AES, AHCO, AKBA, ALBO, ALE, APD, APTV, ARW, ASPS, ATNX, ATRA, ATRS, BCE, BDX, BLDR, BLI, BLL, BRG, BXRX, CARS, CCOI, CFX, CHH, CI, CLDT, CMRX, CNHI, CNP, CNQ, COMM, CPE, CS, CTXS, CWEN, CYBR, DBRG, DEN, DIN, DISH, DLX, DNB, DOCN, DUK, EPAM, ERJ, ESTE, EURN, EVA, FIS, FW...

Provention Bio (NASDAQ:PRVB) is scheduled to announce Q3 earnings results on Thursday, November 4th, before market open. The consensus EPS Estimate is -$0.52 and the consensus Revenue Estimate is $1.25M Over the last 3 months, EPS estimates have seen 4 upward revisions and 0 downward. Revenue...